Lubbad Loay, Öberg Carl M, Dhanasekaran Subramanian, Nemmar Abderrahim, Hammad Fayez, Pathan Javed Y, Rippe Bengt, Bakoush Omran
Department of Surgery, College of Medicine & Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Department of Nephrology, Clinical Sciences Lund, Lund University, Lund, Sweden.
Physiol Rep. 2015 May;3(5). doi: 10.14814/phy2.12397.
Microalbuminuria is an early manifestation of diabetic nephropathy. Potential contributors to this condition are reduced glomerular filtration barrier (GFB) size- and charge selectivity, and impaired tubular reabsorption of filtered proteins. However, it was recently reported that no significant alterations in charge selectivity of the GFB occur in early experimental diabetic nephropathy. We here aimed at investigating the functional changes in the GFB in long-term type-1 diabetes in rats, applying a novel distributed two-pore model. We examined glomerular permeability in 15 male Wistar rats with at least 3 months of streptozotocin (STZ)-induced diabetes (blood glucose ∼20 mmol/L) and in age-matched control rats. The changes in glomerular permeability were assessed by determining the glomerular sieving coefficients (θ) for FITC-Ficoll (molecular radius 20-90 Å) using size exclusion HPLC. The values of θ for FITC-Ficoll of radius >50 Å were significantly increased in STZ-diabetic rats compared to age-matched controls (θ for 50-69 Å = 0.001 vs. 0.0002, and θ for 70-90 Å = 0.0007 vs. 0.00006, P < 0.001), while θ for FITC-Ficoll <50 Å tended to be lower in diabetic rats than in controls (θ for 36-49 Å = 0.013 vs. 0.016, ns). According to the distributed two-pore model, there was primarily an increase in macromolecular transport through large pores in the glomerular filter of diabetic rats associated with a loss of small-pore area. Deterioration in the glomerular size selectivity due to an increase in the number and size-spread of large pores, with no changes in the permeability of the small-pore system, represent the major functional changes observed after 3 months of induced experimental diabetes.
微量白蛋白尿是糖尿病肾病的早期表现。导致这种情况的潜在因素包括肾小球滤过屏障(GFB)的大小和电荷选择性降低,以及肾小管对滤过蛋白的重吸收受损。然而,最近有报道称,在早期实验性糖尿病肾病中,GFB的电荷选择性没有显著改变。我们在此旨在应用一种新型的分布式双孔模型,研究大鼠长期1型糖尿病中GFB的功能变化。我们检查了15只雄性Wistar大鼠的肾小球通透性,这些大鼠患有至少3个月的链脲佐菌素(STZ)诱导的糖尿病(血糖约20 mmol/L),并与年龄匹配的对照大鼠进行比较。通过使用尺寸排阻HPLC测定FITC-菲可(分子半径20 - 90 Å)的肾小球筛分系数(θ)来评估肾小球通透性的变化。与年龄匹配的对照相比,STZ糖尿病大鼠中半径>50 Å的FITC-菲可的θ值显著增加(50 - 69 Å的θ = 0.001对0.0002,70 - 90 Å的θ = 0.0007对0.00006,P < 0.001),而糖尿病大鼠中FITC-菲可<50 Å 的θ值往往低于对照组(36 - 49 Å的θ = 0.013对0.016,无显著性差异)。根据分布式双孔模型,主要是糖尿病大鼠肾小球滤过器中大孔的大分子转运增加,同时小孔面积减少。由于大孔数量和大小分布增加导致肾小球大小选择性恶化,而小孔系统的通透性没有变化,这代表了诱导实验性糖尿病3个月后观察到的主要功能变化。